GRAIL Inc. (NASDAQ: GRAL) announced it will present data from two clinical studies of its Galleri multi-cancer early detection test ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE